Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Redman

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of the American Academy of Dermatology|November 20, 2023
Merkel cell carcinoma recurrence risk estimation is improved by integrating factors beyond cancer stage: A multivariable model and web-based calculatorAubriana M McEvoy, Daniel S Hippe, Kristina Lachance, et al.
Frontiers in Oncology|September 7, 2013
A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung CancerYuhchyau Chen, James Moon, Kishan J Pandya, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 4, 2011
Phase II study of cediranib in patients with malignant pleural mesothelioma: SWOG S0509Linda L Garland, Kari Chansky, Antoinette J Wozniak, et al.
International Journal of Radiation Oncology, Biology, Physics|September 8, 2018
Effect of Patient Immune Status on the Efficacy of Radiation Therapy and Recurrence-Free Survival Among 805 Patients With Merkel Cell CarcinomaYolanda D Tseng, Macklin H Nguyen, Kelsey Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2014
Southwest Oncology Group S0802: a randomized, phase II trial of weekly topotecan with and without ziv-aflibercept in patients with platinum-treated small-cell lung cancerJeffrey W Allen, James Moon, Mary Redman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2004
HIV infection and human herpesvirus-8 oral shedding among men who have sex with menCorey Casper, Mary Redman, Meei-Li Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222Quynh-Thu X Le, James Moon, Mary Redman, et al.
Advances in Radiation Oncology|January 24, 2022
Clinical Outcomes After Proton Beam Therapy for Locally Advanced Non-Small Cell Lung Cancer: Analysis of a Multi-institutional Prospective RegistryAurélien Jongen, Florian Charlier, Kelsey Baker, et al.
AIDS Research and Human Retroviruses|August 17, 2004
Human leukocyte antigen (HLA) B*18 and protection against mother-to-child HIV type 1 transmissionCarey Farquhar, Sarah Rowland-Jones, Dorothy Mbori-Ngacha, et al.
The Laryngoscope|December 2, 2016
Predictors of outcome with cetuximab and paclitaxel for head and neck squamous cell carcinomaBruna Pellini Ferreira, Mary Redman, Kelsey K Baker, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of the American Academy of Dermatology|November 20, 2023
Merkel cell carcinoma recurrence risk estimation is improved by integrating factors beyond cancer stage: A multivariable model and web-based calculatorAubriana M McEvoy, Daniel S Hippe, Kristina Lachance, et al.
Frontiers in Oncology|September 7, 2013
A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung CancerYuhchyau Chen, James Moon, Kishan J Pandya, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 4, 2011
Phase II study of cediranib in patients with malignant pleural mesothelioma: SWOG S0509Linda L Garland, Kari Chansky, Antoinette J Wozniak, et al.
International Journal of Radiation Oncology, Biology, Physics|September 8, 2018
Effect of Patient Immune Status on the Efficacy of Radiation Therapy and Recurrence-Free Survival Among 805 Patients With Merkel Cell CarcinomaYolanda D Tseng, Macklin H Nguyen, Kelsey Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2014
Southwest Oncology Group S0802: a randomized, phase II trial of weekly topotecan with and without ziv-aflibercept in patients with platinum-treated small-cell lung cancerJeffrey W Allen, James Moon, Mary Redman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2004
HIV infection and human herpesvirus-8 oral shedding among men who have sex with menCorey Casper, Mary Redman, Meei-Li Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222Quynh-Thu X Le, James Moon, Mary Redman, et al.
Advances in Radiation Oncology|January 24, 2022
Clinical Outcomes After Proton Beam Therapy for Locally Advanced Non-Small Cell Lung Cancer: Analysis of a Multi-institutional Prospective RegistryAurélien Jongen, Florian Charlier, Kelsey Baker, et al.
AIDS Research and Human Retroviruses|August 17, 2004
Human leukocyte antigen (HLA) B*18 and protection against mother-to-child HIV type 1 transmissionCarey Farquhar, Sarah Rowland-Jones, Dorothy Mbori-Ngacha, et al.
The Laryngoscope|December 2, 2016
Predictors of outcome with cetuximab and paclitaxel for head and neck squamous cell carcinomaBruna Pellini Ferreira, Mary Redman, Kelsey K Baker, et al.
Pageof 4